公司资料
Vertex Pharmaceuticals Incorporated 股价、新闻与催化剂
- 股票代码:
- VRTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
515.55 USD (+1.94%)
收盘价
最后更新: 2026年8月17日
108B USD
市值
股价为何变动
As of Aug 17, 2026, VRTX closed up 1.94% at $515.55. No new same-company headline was identified in the current news window.
公司概览
业务概览
Vertex Pharmaceuticals is a global biotechnology company best known for its leadership in cystic fibrosis. The company has expanded beyond CF into gene editing, pain, and other high-value disease areas, making it one of the most important growth stories in biotech.
所在地与行业分类
Vertex is headquartered in the United States and listed on NASDAQ. It has a global commercial footprint and a premium biotech profile.
商业模式特征
The company generates value from blockbuster product sales, disciplined R&D reinvestment, and a pipeline that extends beyond its core franchise. Investors watch CF execution, pipeline expansion, and whether new programs can preserve growth duration.
生物医药行业定位
Vertex occupies the top tier of biotechnology because it combines commercial strength with innovation depth. It is less binary than a development-stage stock, but its pipeline still matters a great deal.
未来催化剂
- Vertex's catalysts are ALYFTREK label expansion across the CF franchise and suzetrigine's pain filings and Phase 3 progression. The market will care about whether CF can keep compounding while the pain program turns into a second growth engine, because that is what keeps the long-duration story intact.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。